Debel Marlene
- SEC CIK
- 0001770295
In the past year, 1 open-market sale filing worth $1.74M and no purchases.
Current role at each company
- MET Metlife IncEVP & Chief Risk Officeras of Sep 2, 2026
- RJF Raymond James Financial IncDirectoras of Feb 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.74M
- 1 filing
- Net
- −$1.74M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Debel Marlene as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MET Metlife Inc
EVP & Chief Risk Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Debel MarleneEVP & Chief Risk Officer | SSale | −21.3K | $81.59 | −$1.74M | −12.1%154.4K after | |
| Dec 17, 2024 (view filing) | Dec 13 | 4 days | Debel MarleneEVP & Chief Risk Officer | SSale | −22.8K | $82.88 | −$1.89M | −17.4%108.5K after | |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Debel MarleneEVP & Chief Risk Officer | SSale | −9.39K | $63.18 | −$593.3K | −10.8%77.6K after | |
| Aug 23, 2022 (view filing) | Aug 19 | 4 days | Debel MarleneEVP & Chief Risk Officer | SSale | −4.06K | $67.60 | −$274.5K | −6.8%55.3K after |